中西医结合治疗甲型H1N1流感26例

目的观察痰热清注射液联合奥司他韦治疗甲型H1N1流感的临床疗效。方法将确诊的50例甲型H1N1流感患者随机分为治疗组与对照组,两组均采用奥司他韦抗病毒治疗,治疗组加用痰热清注射液静脉滴注,治疗3-10 d。观察并比较两组咳嗽消失时间及临床疗效。结果治疗组和对照组总有效率分别为80.77%、54.17%,两组临床总有效率比较,差异具有统计学意义（P〈0.05）。治疗组咳嗽消失时间较对照组显著缩短（P〈0.05）。结论痰热清注射液联合奥司他韦治疗甲型H1N1流感能明显提高疗效,缩短疗程。

CDMA2000 1x(EV-DO)在甲型H1N1流感应急演练中的应用

CDMA2000 1x(EV-DO)是CDMA2000 1x增强型技术,它支持高速无线互联分组数据的传输,是目前高性能、低成本的无线高速数据传输解决方案。南京市卫生局在甲型H1N1流感防控专项应急演练中,使用了新一代基于CDMA2000 1x(EV-DO)的无线视频监控平台。该平台整合了CDMA无线互联技术、互联网技术、视频压缩技术、计算机处理技术等。应急指挥中心可以通过无线视频监控平台实时掌握现场情况,及时地进行应急处置。

Effect of Rorrico, extracted from group of Chinese medicines, on influenza A and H1N1 infections

OBJECTIVE: To investigate the therapeutic and preventive effects of Rorrico on influenza, especially influenza A viral infection, including swine flu(H1N1)in humans.METHODS: Eighty-nine subjects were recruited in Hong Kong and Macao, and divided into treatment group(TG) and prevention group(PG) based on their influenza A and swine flu symptoms. All subjects were prescribed Rorrico or placebo, and monitored by a Chinese medicine practitioner. Blood samples were collected before and after 7-day Rorrico or placebo treatment for laboratory investigations.RESULTS: After treatment, there were some full recoveries and obvious relief of onset symptoms in the TG. Blood test results showed that Rorrico produced(a) no adverse effects on subjects' renal andliver functions, muscle enzyme and hematological status,(b) no up-regulation of pro-inflammatory cytokines tumour necrosis factor-a and interleukin-18 in both TG and PG,(c) mild yet statistically significant elevation of plasma mannose-binding lectin(MBL) in PG.CONCLUSION: Rorrico has no up-regulating effect on the participants' immune response, or, equally likely, the immuno-modulatory effects of Rorrico do not non-specifically or unnecessarily promote inflammation when not required. It is possible that oral administration of Rorrico can promote hepatic synthesis of MBL in healthy PG subjects, thereby conferring increased protection against infection.

白细胞介素1α基因单核苷酸多态性与甲型H1N1流感易感性的关系

目的探讨白细胞介素1α（IL-1α）基因单核苷酸多态性（SNP）与甲型H1N1流感易感性的关系。方法从IL-1α基因启动子区域中选取4个SNP位点rsl800587、rs2856836、rs2856838、rs3783525，针对以上位点建立基于飞行时间质谱分析技术（TOF—MS）鉴定SNP的方法，对167例H1N1流感患者（H1N1组）和192例健康对照人群（对照组）进行检测。确定各SNP位点的等位基因和基因分型；对比两组等位基因和各基因型的频率。结果rsl800587、rs2856836、rs2856838位点具有T和C两种等位基因，包括Tr、TC、CC3种基因型。rs3783525具有A和T两种等位基因，包括AA、AT和Tl 3种基因型。HINl组和对照组rsl800587位点的等位基因频率差异有统计学意义（X2=12．69，P=0．000，OR=2．424，95％CI=1．472～3．993），rs2856836，rs2856838，rs3783525等位基因频率在H1N1组和对照组中差异则无统计学意义。H1N1组rsl800587位点CC纯合子频率低于对照组[72．5％（121／167）比87．0％（167／192），P〈0．05]，杂合子（TC）频率高于对照组125．1％（42／167）比12．5％（24／192），P〈0．05]，而两组Tr纯合子频率差异则不具有统计学意义。H1N1组rs2856836位点杂合子（TC）频率高于对照组[25．7％（43／167）比17．2％（33／192），P〈0．05]，TT基因型与CC基因型频率在两组间差异均没有统计学意义。rs2856838位点对照组TT纯合子频率低于H1N1组[4．2％（8／192）比10．8％（18／167），P〈0．05]，其余2种基因型Tc与cc在两组间差异没有统计学意义。H1N1组rs3783525位点TT纯合子频率高于对照组[21．0％（35／167）比13．0％（25／192），P〈0．05]，两组间的另两种基因型TC与cc差异也没有统计学意义。结论IL-1α仅基因多态性位点rsl800587、rs2856836、rs2856838、rs3783525与甲型H1N1流感易感性相关。

136例甲型H1N1流感的诊治

目的总结甲型H1N1流感的临床诊治经验,探讨诊治方法。方法对北京市怀柔区第一医院收治确诊的136例甲型H1N1流感的临床特点、救治及转归进行回顾性分析。结果患者临床表现主要为发热、咽痛等,经过抗病毒、抗感染、中医中药治疗后,治愈134例,死亡2例。结论对甲型H1N1流感轻症患者应采取抗病毒对症治疗,甲型H1N1流感重症患者强调抗病毒同时抗感染治疗效果好。